AP2007004058A0 - Novel spirotropane compounds and methods for the modulation of chemokine receptor activity - Google Patents

Novel spirotropane compounds and methods for the modulation of chemokine receptor activity

Info

Publication number
AP2007004058A0
AP2007004058A0 AP2007004058A AP2007004058A AP2007004058A0 AP 2007004058 A0 AP2007004058 A0 AP 2007004058A0 AP 2007004058 A AP2007004058 A AP 2007004058A AP 2007004058 A AP2007004058 A AP 2007004058A AP 2007004058 A0 AP2007004058 A0 AP 2007004058A0
Authority
AP
ARIPO
Prior art keywords
modulation
methods
chemokine receptor
receptor activity
novel
Prior art date
Application number
AP2007004058A
Other languages
English (en)
Inventor
Chung Kong Laval Chan
Marc Courchesne
Louis Baillan-Court
Original Assignee
Virochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virochem Pharma Inc filed Critical Virochem Pharma Inc
Publication of AP2007004058A0 publication Critical patent/AP2007004058A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2007004058A 2004-12-09 2005-12-09 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity AP2007004058A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63426604P 2004-12-09 2004-12-09
US69305105P 2005-06-23 2005-06-23
PCT/CA2005/001878 WO2006060919A1 (en) 2004-12-09 2005-12-09 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity

Publications (1)

Publication Number Publication Date
AP2007004058A0 true AP2007004058A0 (en) 2007-08-31

Family

ID=36577643

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004058A AP2007004058A0 (en) 2004-12-09 2005-12-09 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity

Country Status (13)

Country Link
US (1) US7960403B2 (xx)
EP (1) EP1831222A4 (xx)
JP (1) JP2008522986A (xx)
KR (1) KR20070095310A (xx)
AP (1) AP2007004058A0 (xx)
AU (1) AU2005313813B2 (xx)
BR (1) BRPI0518859A2 (xx)
CA (1) CA2587508A1 (xx)
EA (1) EA200701248A1 (xx)
MX (1) MX2007006776A (xx)
NZ (1) NZ555624A (xx)
SG (1) SG158111A1 (xx)
WO (1) WO2006060919A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709642B2 (en) 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
WO2006060918A1 (en) 2004-12-09 2006-06-15 Virochem Pharma Inc. Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
JP2008522986A (ja) 2004-12-09 2008-07-03 ヴァイロケム・ファーマ・インコーポレーテッド 新規スピロトロパン化合物およびケモカイン受容体活性を調節するための方法
WO2007143847A1 (en) * 2006-06-14 2007-12-21 Virochem Pharma Inc. Spirotropane compounds
RU2565766C1 (ru) * 2014-11-17 2015-10-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Л. Гольдберга" 4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5407938A (en) * 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
US6166209A (en) * 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
WO2001066546A1 (fr) 2000-03-09 2001-09-13 Mitsubishi Pharma Corporation Composes spiro, leur procede de preparation et leur utilisation comme medicaments
WO2002013824A1 (en) 2000-08-17 2002-02-21 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
JP2006511500A (ja) * 2002-10-30 2006-04-06 メルク　エンド　カムパニー　インコーポレーテッド γ−アミノアミド系のケモカイン受容体活性調節剤
CA2573951A1 (en) * 2003-07-18 2005-01-27 Virochem Pharma Inc. Spiro compounds and methods for the modulation of chemokine receptor activity
WO2005023809A1 (en) 2003-09-10 2005-03-17 Virochem Pharma Inc. Spiro compounds and methods for the modulation of chemokine receptor activity
EP1786816A4 (en) * 2003-09-10 2009-11-04 Virochem Pharma Inc SPIROHYDANTOIN COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
US7709642B2 (en) 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
JP2008522986A (ja) 2004-12-09 2008-07-03 ヴァイロケム・ファーマ・インコーポレーテッド 新規スピロトロパン化合物およびケモカイン受容体活性を調節するための方法
WO2006060918A1 (en) 2004-12-09 2006-06-15 Virochem Pharma Inc. Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
WO2007143847A1 (en) 2006-06-14 2007-12-21 Virochem Pharma Inc. Spirotropane compounds

Also Published As

Publication number Publication date
US7960403B2 (en) 2011-06-14
WO2006060919A1 (en) 2006-06-15
CA2587508A1 (en) 2006-06-15
BRPI0518859A2 (pt) 2008-12-09
AU2005313813B2 (en) 2011-04-14
KR20070095310A (ko) 2007-09-28
SG158111A1 (en) 2010-01-29
AU2005313813A1 (en) 2006-06-15
MX2007006776A (es) 2007-07-09
EP1831222A1 (en) 2007-09-12
NZ555624A (en) 2009-09-25
EP1831222A4 (en) 2009-10-21
EA200701248A1 (ru) 2007-12-28
US20080267906A1 (en) 2008-10-30
JP2008522986A (ja) 2008-07-03

Similar Documents

Publication Publication Date Title
EP1718308A4 (en) PROCESS FOR MODULATING NEUROTROPHINE-MEDIATED ACTIVITY
EP1718152A4 (en) AMINOCYCLOPENTYL MODULATORS PYRIDOPYRAZINONE OF CHEMOKINE RECEPTOR ACTIVITY
EP1656138A4 (en) SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
HUE061093T2 (hu) Eljárás katalitikus anyagok elõállítására
IL191554A0 (en) Lactam compounds and methods of using the same
AP2314A (en) 3- 4-heteroarylcyclohexylamino cyclopentanecarboxamides as modulators of chemokine receptors.
EP1558250A4 (en) GAMMA AMINOAMIDE MODULATORS OF THE CHEMOKIN RECEPTOR ACTIVITY
IL186091A0 (en) Enzyme and receptor modulation
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
IL189976A0 (en) Methods of modulating neurotrophin-mediated activity
SG156691A1 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
IL181104A0 (en) Methods and compositions for modulating sphingosine-1-phosphate (sip) receptor activity
IL179462A0 (en) Use of the receptor gpr86
EP1784175A4 (en) INHIBITORS OF ACT ACTIVITY
EP1737861A4 (en) INHIBITORS OF AKT ACTIVITY
ZA200803452B (en) Modulation of glucocorticoid receptor expression
IL175958A0 (en) Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
EP1558599A4 (en) HETEROARYLPIPERIDINE MODULATORS DERCHEMOKIN RECEPTORACTIVITY
EP1732552A4 (en) 2,6-DISUBSTITUTED PIPERIDINES, MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
EP1716134A4 (en) AMINO HETEROCYCLIC COMPOUNDS MODULATING CHEMOKINE RECEPTOR ACTIVITY
EP1806147A4 (en) USE OF IMMUNOSUPPRESSIVE RECEPTOR
EP1824849A4 (en) INHIBITORS OF AKT ACTIVITY
AP2007004058A0 (en) Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
EP1805225A4 (en) CATALYST FOR PROPYLENE POLYMERIZATION AND PROCESS FOR PROPYLENE POLYMERIZATION USING THE CATALYST
EP1824853A4 (en) NEW SPIROTROPAN COMPOUNDS AND METHOD FOR MODULATING THE ACTIVITY OF THE CHEMOKIN RECEPTOR